In Vivo postnatal loss of mature osteoblasts creates an immunosuppressive bone marrow microenvironment to permit the engraftment and proliferation of myeloma cells
Observational analysis revealed reduced bone mineral density and rapid myeloma growth in mice lacking osteoblasts, implying that osteoblasts regulate the tumor microenvironment.
Key Points
Myeloma cell proliferation occurs alongside a loss of osteoblasts, enhancing a supportive tumor microenvironment.
BLI detected a 600-fold increase in tumor burden after osteoblast depletion in an immunocompetent mouse model.
OC-Cre/iDTR mice were analyzed post-Diphtheria Toxin treatment to observe changes in bone structure and myeloma cell behavior.
Findings highlight the role of osteoblasts in controlling myeloma progression, suggesting new therapeutic pathways.